iRay Technology Co., Ltd.

iRay Technology Co., Ltd. faced a notable stock decline on October 13, 2025, amid challenges in the Pharmaceuticals & Biotechnology sector. Despite a strong year-to-date performance, the company reported a significant profit drop and maintains a high price-to-earnings ratio, reflecting its premium valuation amidst market volatility.

iRay Technology Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market. Despite a strong annual return of over 61%, the company has faced challenges, including three consecutive quarters of negative results and a notable profit decline. Financial metrics indicate a high valuation and conservative leverage.